Interestingly, it was found that drugs targeting phosphoinositide 3-kinase/mammalian target of rapamycin (PI3K/mTOR) signaling were broadly associated with multiple eRNAQTL-eRNAs across different cancer types (Fig. 2f; Additional file 2: Fig. S6). This evidence concerns the gene MTOR and cancer.